Stang PE - Search Results

1

Validation of a common data model for active safety surveillance research.

Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Overhage JM, et al. Among authors: stang pe. J Am Med Inform Assoc. 2012 Jan-Feb;19(1):54-60. doi: 10.1136/amiajnl-2011-000376. Epub 2011 Oct 28. J Am Med Inform Assoc. 2012. PMID: 22037893 Free PMC article.

2

Evaluation of alternative standardized terminologies for medical conditions within a network of observational healthcare databases.

Reich C, Ryan PB, Stang PE, Rocca M. Reich C, et al. Among authors: stang pe. J Biomed Inform. 2012 Aug;45(4):689-96. doi: 10.1016/j.jbi.2012.05.002. Epub 2012 Jun 7. J Biomed Inform. 2012. PMID: 22683994 Free article.

3

Managing data quality for a drug safety surveillance system.

Hartzema AG, Reich CG, Ryan PB, Stang PE, Madigan D, Welebob E, Overhage JM. Hartzema AG, et al. Among authors: stang pe. Drug Saf. 2013 Oct;36 Suppl 1:S49-58. doi: 10.1007/s40264-013-0098-7. Drug Saf. 2013. PMID: 24166223

4

A comparison of the empirical performance of methods for a risk identification system.

Ryan PB, Stang PE, Overhage JM, Suchard MA, Hartzema AG, DuMouchel W, Reich CG, Schuemie MJ, Madigan D. Ryan PB, et al. Among authors: stang pe. Drug Saf. 2013 Oct;36 Suppl 1:S143-58. doi: 10.1007/s40264-013-0108-9. Drug Saf. 2013. PMID: 24166231

5

Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers.

Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong IC, Rijnbeek PR, van der Lei J, Pratt N, Norén GN, Li YC, Stang PE, Madigan D, Ryan PB. Hripcsak G, et al. Among authors: stang pe. Stud Health Technol Inform. 2015;216:574-8. Stud Health Technol Inform. 2015. PMID: 26262116 Free PMC article.

6

Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership.

Stang PE, Ryan PB, Racoosin JA, Overhage JM, Hartzema AG, Reich C, Welebob E, Scarnecchia T, Woodcock J. Stang PE, et al. Ann Intern Med. 2010 Nov 2;153(9):600-6. doi: 10.7326/0003-4819-153-9-201011020-00010. Ann Intern Med. 2010. PMID: 21041580

7

Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership.

Ryan PB, Madigan D, Stang PE, Overhage JM, Racoosin JA, Hartzema AG. Ryan PB, et al. Among authors: stang pe. Stat Med. 2012 Dec 30;31(30):4401-15. doi: 10.1002/sim.5620. Epub 2012 Sep 27. Stat Med. 2012. PMID: 23015364

8

Evaluating the impact of database heterogeneity on observational study results.

Madigan D, Ryan PB, Schuemie M, Stang PE, Overhage JM, Hartzema AG, Suchard MA, DuMouchel W, Berlin JA. Madigan D, et al. Among authors: stang pe. Am J Epidemiol. 2013 Aug 15;178(4):645-51. doi: 10.1093/aje/kwt010. Epub 2013 May 5. Am J Epidemiol. 2013. PMID: 23648805 Free PMC article.

9

Desideratum for evidence based epidemiology.

Overhage JM, Ryan PB, Schuemie MJ, Stang PE. Overhage JM, et al. Among authors: stang pe. Drug Saf. 2013 Oct;36 Suppl 1:S5-14. doi: 10.1007/s40264-013-0102-2. Drug Saf. 2013. PMID: 24166219 Review.

10

Variation in choice of study design: findings from the Epidemiology Design Decision Inventory and Evaluation (EDDIE) survey.

Stang PE, Ryan PB, Overhage JM, Schuemie MJ, Hartzema AG, Welebob E. Stang PE, et al. Drug Saf. 2013 Oct;36 Suppl 1:S15-25. doi: 10.1007/s40264-013-0103-1. Drug Saf. 2013. PMID: 24166220

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters